ME/CFS typically starts suddenly with severe tiredness and flu-like symptoms that come and go over months or years. While blood tests sometimes show immune system changes, doctors diagnose ME/CFS mainly by recognizing the pattern of symptoms and ruling out other illnesses. Current treatment focuses on managing symptoms and helping patients cope with this long-lasting, disabling condition.
Why It Matters
This work provides clinicians with practical diagnostic guidance for ME/CFS and acknowledges that currently available biomarkers cannot definitively confirm disease, validating patients' experiences of a real illness despite normal physical examinations. It highlights the need for better diagnostic tools and underscores that symptom management and psychosocial support remain core therapeutic approaches.
Observed Findings
ME/CFS typically presents with sudden onset of severe fatigue and flu-like symptoms
Symptoms characteristically relapse and remit, persisting for years in many cases
Physical examination findings are minor and nonspecific despite significant illness
Immunological abnormalities are found in many ME/CFS cases but lack diagnostic specificity
Immunological testing remains expensive and is reserved primarily for research rather than clinical diagnosis
Inferred Conclusions
Clinical diagnosis of ME/CFS must be based on symptom pattern and exclusion of other diagnoses, not laboratory confirmation
Current immunological tests are inadequate for routine clinical diagnostic purposes
Treatment strategies should prioritize symptom relief and psychosocial adjustment to chronic disability
Better diagnostic biomarkers are needed to improve diagnostic accuracy and clinical confidence
Remaining Questions
What causes the immunological abnormalities observed in ME/CFS, and do they play a causal role in disease pathogenesis?
What specific treatment interventions most effectively improve symptom burden and quality of life?
What This Study Does Not Prove
This review does not establish the underlying biological cause of ME/CFS or explain why immunological abnormalities occur. It does not prove that symptomatic treatment is curative or optimal, only that it represents current practice. It cannot determine whether immunological changes are causative, consequential, or merely associated with disease.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.